Norwalk Leslie V
- SEC CIK
- 0001533568
In the past year, 6 open-market sale filings worth $2.53M and no purchases.
Current role at each company
- NBIX Neurocrine Biosciences IncDirectoras of Jul 30, 2026
- ARVN Arvinas, Inc.Directoras of Jun 26, 2026
- CVS CVS Health CorpDirectoras of May 15, 2026
- GMED Globus Medical IncDirectoras of Jan 23, 2026
- MODV ModivCare IncDirectoras of Feb 16, 2024
Show 3 more companies
- NUVA Nuvasive IncDirectoras of Sep 5, 2023
- CNC Centene CorpDirectoras of Apr 4, 2022
- MGLN Magellan Health IncDirectoras of Jan 4, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $2.53M
- 6 filings
- Net
- −$2.53M
- Bought minus sold
- Companies
- 2
- With open-market trades
Trades
Every Form 4 that lists Norwalk Leslie V as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
NBIX Neurocrine Biosciences Inc
Director6 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 29, 2024 (view filing) | Feb 27 | 2 days | Norwalk Leslie VDirector | SSale | −8.00K | $135.67 | −$1.09M | −100.0%0 after | 10b5-1 |
| May 21, 2024 (view filing) | May 17 | 4 days | Norwalk Leslie VDirector | SSale | −1.11K | $141.82 | −$156.9K | −52.7%994 after | 10b5-1 |
| Dec 17, 2025 (view filing) | Dec 15-16 | 2 days | Norwalk Leslie VDirector | SSale | −6.19K | $152.78 | −$945.7K | −49.8%6.24K after | 2 lots10b5-1 |
| May 14, 2026 (view filing) | May 12 | 2 days | Norwalk Leslie VDirector | SSale | −3.81K | $155.01 | −$590.6K | −61.1%2.43K after | 10b5-1 |
| Jun 8, 2026 (view filing) | Jun 4 | 4 days | Norwalk Leslie VDirector | SSale | −1.25K | $168.06 | −$210.1K | −30.6%2.84K after | 10b5-1 |
| Jul 30, 2026 (view filing)5:29 PM ET | Jul 28 | 2 days | Norwalk Leslie VDirector | SSale | −1.25K | $182.01 | −$227.5K | −44.0%1.59K after | 10b5-1 |
GMED Globus Medical Inc
Director4 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 19, 2024 (view filing) | Mar 15 | 4 days | Norwalk Leslie VDirector | SSaleClass A Common Stock | −10.6K | $51.99 | −$550.6K | −37.8%17.4K after | 10b5-1 |
| Jul 15, 2024 (view filing) | Jul 11 | 4 days | Norwalk Leslie VDirector | SSaleClass A Common Stock | −1.00K | $70.00 | −$70.0K | −5.7%16.4K after | 10b5-1 |
| Dec 16, 2025 (view filing) | Dec 12 | 4 days | Norwalk Leslie VDirector | SSaleClass A Common Stock | −4.00K | $88.85 | −$355.4K | −24.4%12.4K after | 10b5-1 |
| Jan 12, 2026 (view filing) | Jan 8 | 4 days | Norwalk Leslie VDirector | SSaleClass A Common Stock | −2.00K | $101.10 | −$202.2K | −16.1%10.4K after | 10b5-1 |